免疫原性
树突状细胞
下调和上调
TLR9型
细胞生物学
CpG站点
融合蛋白
癌症研究
细胞毒性T细胞
交叉展示
生物
CpG寡核苷酸
磷酸化
抗原
抗原呈递
转染
激酶
乙酰化
免疫疗法
免疫学
化学
衰老
免疫系统
嵌合抗原受体
细胞毒性
T细胞
细胞
作者
Qingxu Song,Xiaoxue Du,Wenbo Dong,Ying Wang,Xiaojing Wang,Qiliang Yin
摘要
ABSTRACT Senolytic vaccines hold promise for eliminating senescent cells, but their efficacy is limited by poor seno‐antigen immunogenicity and age‐related dendritic cell (DC) dysfunction. Here, we engineered an active biomaterial‐enabled bi‐adjuvant senolytic nanovaccine (CK5‐GC‐NV) by co‐assembling CpG oligodeoxynucleotide with a fusion protein of the seno‐antigen Gpnmb and a cationic spider silk protein variant (CK5). Beyond antigen delivery, the CK5 scaffold acts as an intrinsic senomodulator associated with the downregulation of mitotic kinases Aurka/b and a concomitant decrease in senescence‐associated PI3K/AKT phosphorylation in DCs. This intervention attenuates aged DC phenotypes, restores antigen cross‐presentation, and synergizes with CpG to elicit potent cytotoxic T‐lymphocyte responses against senescent targets. Across multiple aging mouse models, CK5‐GC‐NV immunization orchestrated targeted clearance of Gpnmb + senescent adipocytes, profoundly ameliorating metabolic dysfunction and extending lifespan. This multifunctional biomaterial platform integrates seno‐antigen immunogenicity enhancement with the restoration of aged DC function, providing a promising proof‐of‐concept for antigen‐directed gerotherapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI